| Tüüp : |
Ajaleht |
| Interneti link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=2464 |
|
| Uurimisrühmad : |
Houston - M.D.Anderson Cancer Center |
| Autor : |
Trissel LA, Zhang Y, Koontz SE. |
| Pealkiri : |
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
| Publikatsioon : |
Int J Pharm Compound ; 10, 5: 396-399. 2006 |
|
| Tõendite tase : |
|
| Füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
Ingredientide nimekiri
 Temozolomide
|
 |
 |
 |
Povidone K30 |
 |
 |
 |
 |
 |
300 mg
Temodar® |
| Povidone K30 |
150 mg |
| Veevaba sidrunhape |
7.5 mg |
| Puhastatud vesi |
0.45 ml |
| OraPlus® |
15 ml |
| Orasweet® |
>> 30 ml |
|
4°C |
 |
| 60 |
 |
|
|
|
|
|
300 mg
Temodar® |
| Povidone K30 |
150 mg |
| Veevaba sidrunhape |
7.5 mg |
| Puhastatud vesi |
0.45 ml |
| OraPlus® |
15 ml |
| Orasweet SF ® |
>> 30 ml |
|
4°C |
|
| 60 |
|
|
|
|
|
